[Formulation of HIV protease inhibitors. Pharmaceutical technology and biopharmaceutic aspects of HIV protease inhibitors].
Leopold
C S
CS
Institut für Pharmazie, Pharmazeutische Technologie, Schönauer Str. 160, 04207 Leipzig. cleopold@rz.uni-leipzig.de
D001702:Biopharmaceutics; D004339:Drug Compounding; D017320:HIV Protease Inhibitors / Q000737:chemistry* / Q000493:pharmacokinetics*; D006801:Humans; D013678:Technology, Pharmaceutical
D017320:HIV Protease Inhibitors